MediWound (MDWD) Other Non-Current Liabilities (2013 - 2025)
MediWound's (MDWD) quarterly Other Non-Current Liabilities came in at $8.3 million in Q4 2025, up 1.74% year-on-year from $8.1 million in Q4 2024, and down 2.78% quarter-over-quarter from $8.5 million in Q3 2025.
MediWound (MDWD) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends
MediWound's Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $8.3 million for Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities rose 1.74% year-over-year to $8.3 million in Q4 2025; TTM through Dec 2025 was $8.3 million, a 1.74% increase from a year earlier, with the FY2025 full-year figure at $8.3 million, up 1.74% from the prior year.
- Other Non-Current Liabilities retreated to $8.3 million in Q4 2025 per MDWD's latest filing, from $8.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $8.5 million in Q3 2025 and bottomed at $427000.0 in Q4 2023.
- The 5-year median for Other Non-Current Liabilities is $7.9 million (2022), against an average of $7.2 million.
- Across the five-year window, Other Non-Current Liabilities tumbled 94.26% in 2023 and surged 1808.43% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $918000.0 in 2021, then surged by 711.0% to $7.4 million in 2022, then tumbled by 94.26% to $427000.0 in 2023, then jumped by 1808.43% to $8.1 million in 2024, then increased by 1.74% to $8.3 million in 2025.
- Per Business Quant, the three latest MDWD Other Non-Current Liabilities figures stand at $8.3 million (Q4 2025), $8.5 million (Q3 2025), and $8.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MediWound | 183.16 Mn | 178.36 Mn | 278,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.29 Mn |
| Sep 30, 2025 | 8.53 Mn |
| Jun 30, 2025 | 8.50 Mn |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 8.05 Mn |
| Jun 30, 2024 | 8.01 Mn |
| Mar 31, 2024 | 7.78 Mn |
| Dec 31, 2023 | 427,000.00 |
| Sep 30, 2023 | 7.86 Mn |
| Jun 30, 2023 | 7.81 Mn |
| Mar 31, 2023 | 7.58 Mn |
| Dec 31, 2022 | 7.45 Mn |
| Sep 30, 2022 | 8.45 Mn |
| Jun 30, 2022 | 8.13 Mn |
| Mar 31, 2022 | 7.90 Mn |
| Dec 31, 2021 | 918,000.00 |
| Sep 30, 2021 | 7.72 Mn |
| Jun 30, 2021 | 7.67 Mn |
| Mar 31, 2021 | 7.28 Mn |